DiaMedica Therapeutics Inc. Common Stock
Symbol: DMAC (NASDAQ)
7.38
▲ (3.44%) 0.245
Company Description:
DiaMedica Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is engaged in developing treatment for ischemic diseases with two main clinical programs focused on acute ischemic stroke (AIS) and preeclampsia (PE). Its main product candidate DM199 (rinvecalinase alfa) is a recombinant form of human tissue kallikrein-1, which is a synthetic version of the naturally occurring protease enzyme kallikrein-1 and a rhKLK1 undergoing clinical development studies in both AIS and PE. The other product candidate in the company's pipeline is DM300, its patented recombinant human ulinastatin, a broad-spectrum serine protease inhibitor, being developed as a potential therapy for severe acute pancreatitis.
Key Stats
- Today's Open: $7.02
- Today's High: $7.475
- Today's Low: $6.83
- Today's Volume: 770.80K
- Yesterday Close: $7.13
- Yesterday High: $7.4638
- Yesterday Low: $7.08
- Yesterday Volume: 344.46K
- Last Min Volume: 1.00K
- Last Min High: $7.375
- Last Min Low: $7.375
- Last Min VWAP: $7.375
Company Profile
- Name: DiaMedica Therapeutics Inc. Common Stock
- Website: https://www.diamedica.com
- Listed Date: 2007-11-29
- Location: MINNEAPOLIS, MN
- Market Status: Active
- CIK Number: 0001401040
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $368.54M
- Round Lot: 100
- Outstanding Shares: 51.69M
- Asset Type: CS
RECENT FILINGS FOR DMAC
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-04 | 4 | View |
| 2025-09-04 | SCHEDULE 13G/A | View |
| 2025-08-27 | SCHEDULE 13G | View |
| 2025-08-22 | EFFECT | View |
| 2025-08-22 | 424B2 | View |
| 2025-08-12 | 8-K | View |
| 2025-08-12 | S-3 | View |
| 2025-08-12 | 10-Q | View |
| 2025-08-12 | 8-K | View |
| 2025-08-08 | EFFECT | View |
| 2025-08-06 | CORRESP | View |
| 2025-08-06 | 8-K | View |
| 2025-08-05 | UPLOAD | View |
| 2025-08-01 | S-3 | View |
| 2025-07-30 | SCHEDULE 13G/A | View |
| 2025-07-30 | SCHEDULE 13G/A | View |
| 2025-07-25 | 4 | View |
| 2025-07-25 | 4 | View |
| 2025-07-25 | 4 | View |
| 2025-07-25 | D | View |
Latest News on DMAC